Insider · CIK 0001591178

Klausner Richard

Reports to the SEC for 4 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001591178

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-10	LYELLyell Immunopharma, Inc. · Option (right to buy)A Award	Director	AAward	+9,250 sh	—	—	9,250
2026-06-09	PBLSParabilis Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20.2K sh	—	—	20,215
2025-05-15	LYELLyell Immunopharma, Inc. · Option (right to buy)A Award	Director	AAward	+130K sh	—	—	130,000
2025-03-14	LYELLyell Immunopharma, Inc.P Purchase	Director	PPurchase	+158K sh	$0.60	+$94.9K	843,365
2024-06-14	LYELLyell Immunopharma, Inc. · Option (right to buy)A Award	Director	AAward	+130K sh	—	—	130,000
2023-09-08	LYELLyell Immunopharma, Inc. · Option (right to buy)A Award	Director	AAward	+55K sh	—	—	55,000
2023-08-15	LYELLyell Immunopharma, Inc.S Sale	Director	SSale	−58K sh	$2.28	−$132K	930,880
2023-06-16	LYELLyell Immunopharma, Inc. · Option (right to buy)A Award	Director	AAward	+65K sh	—	—	65,000
2022-09-23	LYELLyell Immunopharma, Inc.S Sale	Director	SSale	−11.1K sh	$6.40	−$71K	988,900
2022-06-08	LYELLyell Immunopharma, Inc. · Option (right to buy)A Award	Director	AAward	+65K sh	—	—	65,000
2021-06-21	LYELLyell Immunopharma, Inc. · Series A Convertible Preferred StockC Conversion	Director	CConversion	−3.77M sh	—	—	0
2021-06-21	LYELLyell Immunopharma, Inc.C Conversion	Director	CConversion	+3.77M sh	—	—	3,765,842
2018-03-05	Juno Therapeutics, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	$63.71	−$765K	0
2018-03-05	Juno Therapeutics, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	$44.60	−$535K	0
2018-03-05	Juno Therapeutics, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	$27.00	−$324K	0
2018-03-05	Juno Therapeutics, Inc.U Disposition from Tender	Director	UDisposition from Tender	−706K sh	$87.00	−$61.4M	0
2018-02-07	Juno Therapeutics, Inc.G Gift	Director	GGift	−23.3K sh	—	—	705,525
2017-12-21	Juno Therapeutics, Inc.S Sale	Director	SSale	−3,141 sh	$45.16	−$142K	741,251
2017-12-21	Juno Therapeutics, Inc.S Sale	Director	SSale	−32.9K sh	$44.72	−$1.47M	744,392
2017-10-05	Juno Therapeutics, Inc.A Award	Director	AAward	+266 sh	—	—	777,251
2017-09-07	Juno Therapeutics, Inc.S Sale	Director	SSale	−1,337 sh	$43.83	−$58.6K	776,985
2017-09-07	Juno Therapeutics, Inc.S Sale	Director	SSale	−5,449 sh	$42.27	−$230K	783,536
2017-09-07	Juno Therapeutics, Inc.S Sale	Director	SSale	−5,214 sh	$42.76	−$223K	778,322
2017-08-07	Juno Therapeutics, Inc.S Sale	Director	SSale	−12K sh	$30.34	−$364K	788,985
2017-07-07	Juno Therapeutics, Inc.S Sale	Director	SSale	−23.6K sh	$29.38	−$693K	801,385
2017-07-07	Juno Therapeutics, Inc.S Sale	Director	SSale	−400 sh	$30.00	−$12K	800,985
2017-07-05	Juno Therapeutics, Inc.A Award	Director	AAward	+380 sh	—	—	824,985
2017-06-16	Juno Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2017-06-07	Juno Therapeutics, Inc.S Sale	Director	SSale	−15.2K sh	$23.23	−$354K	833,373
2017-06-07	Juno Therapeutics, Inc.S Sale	Director	SSale	−8,768 sh	$24.24	−$213K	824,605
2017-04-05	Juno Therapeutics, Inc.A Award	Director	AAward	+514 sh	—	—	848,605
2017-01-05	Juno Therapeutics, Inc.A Award	Director	AAward	+591 sh	—	—	848,091
2016-10-05	Juno Therapeutics, Inc.A Award	Director	AAward	+401 sh	—	—	847,500
2016-07-05	Juno Therapeutics, Inc.A Award	Director	AAward	+300 sh	—	—	847,099
2016-06-24	Juno Therapeutics, Inc.S Sale	Director	SSale	−12K sh	$40.71	−$488K	846,799
2016-06-17	Juno Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2016-05-18	Juno Therapeutics, Inc.S Sale	Director	SSale	−12K sh	$40.00	−$480K	858,799
2016-04-15	Juno Therapeutics, Inc.S Sale	Director	SSale	−1,993 sh	$43.51	−$86.7K	870,799
2016-04-15	Juno Therapeutics, Inc.S Sale	Director	SSale	−10K sh	$42.79	−$428K	872,792
2016-04-05	Juno Therapeutics, Inc.A Award	Director	AAward	+300 sh	—	—	882,799
2016-03-22	Juno Therapeutics, Inc.S Sale	Director	SSale	−12K sh	$40.00	−$480K	882,499
2016-03-02	Juno Therapeutics, Inc.S Sale	Director	SSale	−760 sh	$41.22	−$31.3K	894,499
2016-03-02	Juno Therapeutics, Inc.S Sale	Director	SSale	−23.2K sh	$40.39	−$939K	895,259
2016-01-29	ILMNILLUMINA, INC.F Tax Payment	Sr VP, Chief Medical Officer	FTax Payment	−253 sh	$157.95	−$40K	22,847
2015-12-15	Juno Therapeutics, Inc.S Sale	Director	SSale	−4,215 sh	$44.81	−$189K	926,284
2015-12-15	Juno Therapeutics, Inc.S Sale	Director	SSale	−3,700 sh	$45.74	−$169K	922,584
2015-12-15	Juno Therapeutics, Inc.S Sale	Director	SSale	−4,085 sh	$46.62	−$190K	918,499
2015-11-13	ILMNILLUMINA, INC.S Sale	Sr VP, Chief Medical Officer	SSale	−730 sh	$163.52	−$119K	23,100
2015-11-13	Juno Therapeutics, Inc.S Sale	Director	SSale	−11.5K sh	$49.48	−$569K	930,999
2015-11-13	Juno Therapeutics, Inc.S Sale	Director	SSale	−500 sh	$50.18	−$25.1K	930,499

Recent filings

Accepted (ET)
Jun 124
Klausner Richard0001591178-26-000002
SEC(opens sec.gov)
Jun 114
Klausner Richard0001193125-26-267747
SEC(opens sec.gov)
May 194
Klausner Richard0001415889-25-013723
SEC(opens sec.gov)
Mar 184
Klausner Richard0001415889-25-008540
SEC(opens sec.gov)
Jun 174
Klausner Richard0001415889-24-017176
SEC(opens sec.gov)
Sep 84
Klausner Richard0001209191-23-048788
SEC(opens sec.gov)
Aug 174
Klausner Richard0001209191-23-046267
SEC(opens sec.gov)
Jun 204
Klausner Richard0001209191-23-038439
SEC(opens sec.gov)
Sep 274
Klausner Richard0001209191-22-051379
SEC(opens sec.gov)
Jun 104
Klausner Richard0001209191-22-035825
SEC(opens sec.gov)
Jun 234
Klausner Richard0001209191-21-042798
SEC(opens sec.gov)
Mar 74
Klausner Richard0001209191-18-017815
SEC(opens sec.gov)
Dec 224
Klausner Richard0001209191-17-067084
SEC(opens sec.gov)
Oct 64
Klausner Richard0001209191-17-056351
SEC(opens sec.gov)

Companies

Address

C/O LYELL IMMUNOPHARMA, INC. 201 HASKINS WAY, SUITE 101

SOUTH SAN FRANCISCO, CA, 94080